Curcumin for Pediatric Nonalcoholic Fatty Liver Disease
Status:
Withdrawn
Trial end date:
2020-04-22
Target enrollment:
Participant gender:
Summary
This is a single-center, randomized, double-blinded, placebo-controlled, parallel treatment
groups phase 2a study of curcumin for pediatric nonalcoholic fatty liver disease (NAFLD).